Shift in metabolic substrate uptake by the heart during development of alloxan-induced diabetes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 3 54-3, 2003, Pages

  Linke, Axel ^a   Zhao, Gong ^a   Recchia, Fabio A ^a   Williams, Jeffrey ^a   Xu, Xiaobin ^a   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Free fatty acids; Glucose; Keto acids; Lactate; Myocardium

Indexed keywords

3 HYDROXYBUTYRIC ACID; ALLOXAN; FATTY ACID; GLUCOSE; LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY SINUS; CORONARY VASCULAR RESISTANCE; DIABETES MELLITUS; DOG; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEART DEVELOPMENT; HEART MUSCLE METABOLISM; HYPERGLYCEMIA; LACTATE BLOOD LEVEL; MALE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0042360149     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00528.2002     Document Type: Article

References (19)

1. Avogaro A, Nosadini R, Doria A, Fioretto P, Velussi M, Vigorito C, Sacca L, Toffolo G, Cobelli C, and Trevisan R. Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol Endocrinol Metab 258: E606-E618, 1990.
2. Camici P, Ferrannini E, and Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 32: 217-238, 1989.
3. Doria A, Nosadini R, Avogaro A, Fioretto P, and Crepaldi G. Myocardial metabolism in type 1 diabetic patients without coronary artery disease. Diabet Med 8: S104-S107, 1991.
4. Hambrecht R, Adams V, Gielen S, Linke A, Mobius-Winkler S, Yu J, Niebauer J, Jiang H, Fiehn E, and Schuler G. Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol 33: 174-179, 1999.
5. Hansford RG and Cohen L. Relative importance of pyruvate dehydrogenase interconversion and feed-back inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria. Arch Biochem Biophys 191: 65-81, 1978.
6. Kraupp O, Adler-Kastner L, Kolassa N, Nell G, Plank B, and Chirikdjian JJ. Arterial levels, cardiac and hepatic arteriovenous differences, extraction coefficients and oxygen extraction ratios of various substrates in normal, and in acute and chronic alloxan-diabetic dogs. Eur J Biochem 6: 114-125, 1968.
7. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 23: 321-336, 1981.
8. Manders WT and Vatner SF. Effects of sodium pentobarbital anesthesia on left ventricular function and distribution of cardiac output in dogs, with particular reference to the mechanism for tachycardia. Circ Res 39: 512-517, 1976.
9. Opie LH. Metabolism of the heart in health and disease. Am Heart J 76: 685-698, 1968.
10. Recchia FA, McConnell PI, Bernstein RD, Vogel TR, Xu X, and Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 83: 969-979, 1998.
11. Recchia FA, McConnell PI, Loke KE, Xu X, Ochoa M, and Hintze TH. Nitric oxide controls cardiac substrate utilization in the conscious dog. Cardiovasc Res 44: 325-332, 1999.
12. Recchia FA, Osorio JC, Chandler MP, Xu X, Panchal AR, Lopaschuk GD, Hintze TH, and Stanley WC. Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs. Am J Physiol Endocrinol Metab 282: E197-E206, 2002.
13. Stanley WC, Lopaschuk GD, Hall JL, and McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 33: 243-257, 1997.
14. Stanley WC, Lopaschuk GD, and McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34: 25-33, 1997.
15. Tada H, Thompson CI, Recchia FA, Loke KE, Ochoa M, Smith CJ, Shesely EG, Kaley G, and Hintze TH. Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart. Circ Res 86: 270-274, 2000.
16. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 19: 59-113, 1994.
17. Wieland O, Siess E, Schulze-Wethmar FH, von Funcke HG, and Winton B. Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney: effect of diabetes, fasting, and refeeding on pyruvate dehydrogenase interconversion. Arch Biochem Biophys 143: 593-601, 1971.
18. Wiener R and Spitzer JJ. Substrate utilization by myocardium and skeletal muscle in alloxan-diabetic dogs. Am J Physiol 225: 1288-1294, 1973.
19. Zhao G, Zhang X, Smith CJ, Xu X, Ochoa M, Greenhouse D, Vogel T, Curran C, and Hintze TH. Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes. Am J Physiol Heart Circ Physiol 277: H268-H278, 1999.